Wedbush Securities Inc Amgen Inc Transaction History

Wedbush Securities Inc

  • $2.7 Billion
  • Q3 2024

A detailed history of Wedbush Securities Inc transactions in Amgen Inc stock. As of the latest transaction made, Wedbush Securities Inc holds 32,558 shares of AMGN stock, worth $9.05 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
32,558
Previous 35,329 7.84%
Holding current value
$9.05 Million
Previous $11 Million 4.96%
% of portfolio
0.39%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$309.38 - $337.38 $857,291 - $934,879
-2,771 Reduced 7.84%
32,558 $10.5 Million
Q2 2024

Aug 06, 2024
BUY
$262.75 - $319.31 $225,965 - $274,606
860 Added 2.49%
35,329 $11 Million
Q1 2024

May 14, 2024
BUY
$268.87 - $324.56 $768,161 - $927,267
2,857 Added 9.04%
34,469 $9.8 Million
Q4 2023

Feb 12, 2024
BUY
$255.7 - $288.46 $8,949 - $10,096
35 Added 0.11%
31,612 $9.11 Million
Q3 2023

Nov 14, 2023
BUY
$218.65 - $271.46 $190,225 - $236,170
870 Added 2.83%
31,577 $8.49 Million
Q2 2023

Aug 14, 2023
SELL
$214.27 - $253.37 $592,456 - $700,568
-2,765 Reduced 8.26%
30,707 $6.82 Million
Q1 2023

May 09, 2023
BUY
$225.79 - $275.2 $931,835 - $1.14 Million
4,127 Added 14.06%
33,472 $8.09 Million
Q4 2022

Jan 31, 2023
SELL
$229.03 - $291.01 $351,790 - $446,991
-1,536 Reduced 4.97%
29,345 $7.71 Million
Q3 2022

Oct 18, 2022
BUY
$224.46 - $253.15 $1.05 Million - $1.19 Million
4,698 Added 17.94%
30,881 $6.96 Million
Q2 2022

Jul 21, 2022
SELL
$230.71 - $256.74 $27,915 - $31,065
-121 Reduced 0.46%
26,183 $6.37 Million
Q1 2022

Apr 19, 2022
BUY
$219.27 - $242.57 $8,332 - $9,217
38 Added 0.14%
26,304 $6.36 Million
Q4 2021

Jan 13, 2022
BUY
$198.88 - $227.6 $324,373 - $371,215
1,631 Added 6.62%
26,266 $5.91 Million
Q3 2021

Oct 08, 2021
SELL
$212.27 - $248.7 $40,755 - $47,750
-192 Reduced 0.77%
24,635 $5.24 Million
Q2 2021

Jul 27, 2021
BUY
$233.58 - $259.14 $1.7 Million - $1.89 Million
7,297 Added 41.63%
24,827 $6.05 Million
Q1 2021

Apr 26, 2021
BUY
$221.91 - $258.6 $629,114 - $733,131
2,835 Added 19.29%
17,530 $4.36 Million
Q4 2020

Feb 16, 2021
BUY
$216.38 - $257.67 $211,619 - $252,001
978 Added 7.13%
14,695 $3.38 Million
Q3 2020

Oct 20, 2020
SELL
$234.65 - $260.95 $865,623 - $962,644
-3,689 Reduced 21.19%
13,717 $3.49 Million
Q2 2020

Jul 16, 2020
SELL
$197.81 - $242.74 $52,419 - $64,326
-265 Reduced 1.5%
17,406 $4.11 Million
Q1 2020

Apr 17, 2020
BUY
$182.24 - $241.7 $43,373 - $57,524
238 Added 1.37%
17,671 $3.58 Million
Q4 2019

Jan 16, 2020
BUY
$189.21 - $243.2 $10,974 - $14,105
58 Added 0.33%
17,433 $4.2 Million
Q3 2019

Oct 17, 2019
BUY
$174.11 - $208.62 $107,425 - $128,718
617 Added 3.68%
17,375 $3.36 Million
Q2 2019

Aug 01, 2019
BUY
$166.7 - $195.41 $10,668 - $12,506
64 Added 0.38%
16,758 $3.09 Million
Q1 2019

Apr 17, 2019
SELL
$180.87 - $203.88 $630,512 - $710,725
-3,486 Reduced 17.27%
16,694 $3.17 Million
Q4 2018

Jan 31, 2019
SELL
$178.4 - $208.25 $258,501 - $301,754
-1,449 Reduced 6.7%
20,180 $3.93 Million
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $272,376 - $307,068
1,470 Added 7.29%
21,629 $4.48 Million
Q2 2018

Aug 03, 2018
SELL
$166.05 - $186.51 $194,942 - $218,962
-1,174 Reduced 5.5%
20,159 $3.72 Million
Q1 2018

May 01, 2018
SELL
$169.43 - $198.0 $185,017 - $216,216
-1,092 Reduced 4.87%
21,333 $3.64 Million
Q4 2017

Feb 09, 2018
BUY
$168.79 - $188.59 $128,955 - $144,082
764 Added 3.53%
22,425 $3.9 Million
Q3 2017

Oct 31, 2017
BUY
$167.29 - $191.0 $3.62 Million - $4.14 Million
21,661
21,661 $4.04 Million

Others Institutions Holding AMGN

# of Institutions
3,123
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email